Jefferies Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.12M Buy
+6,500
New +$2.39M 0.02% 580
2022
Q1
Sell
-2,344
Closed -$1.54M 1713
2021
Q4
$1.54M Buy
+2,344
New +$1.47M 0.01% 877
2020
Q4
Sell
-2,000
Closed -$786K 1666
2020
Q3
$786K Sell
2,000
-6,200
-76% -$2.29M 0.01% 865
2020
Q2
$2.71K Buy
8,200
+7,280
+791% +$2.11M 0.03% 453
2020
Q1
$223K Buy
+920
New +$240K ﹤0.01% 1647
2019
Q4
Sell
-1,040
Closed -$283K 2744
2019
Q3
$283K Buy
+1,040
New +$289K ﹤0.01% 2204
2019
Q1
Sell
-8,117
Closed -$1.51M 2467
2018
Q4
$1.51M Buy
8,117
+393
+5% +$80.6K 0.01% 964
2018
Q3
$1.93M Buy
7,724
+3,596
+87% +$873K 0.01% 998
2018
Q2
$900K Sell
4,128
-4,796
-54% -$988K 0.01% 1327
2018
Q1
$1.71M Sell
8,924
-15,228
-63% -$2.81M 0.01% 937
2017
Q4
$3.78M Buy
24,152
+6,473
+37% +$1.02M 0.02% 675
2017
Q3
$2.75M Sell
17,679
-27,405
-61% -$4.33M 0.02% 785
2017
Q2
$7.28M Buy
45,084
+35,743
+383% +$5.8M 0.05% 367
2017
Q1
$1.44M Buy
9,341
+3,611
+63% +$498K 0.01% 1078
2016
Q4
$672K Sell
5,730
-1,144
-17% -$131K ﹤0.01% 1469
2016
Q3
$775K Buy
6,874
+2,356
+52% +$248K ﹤0.01% 1407
2016
Q2
$420K Sell
4,518
-9,199
-67% -$790K ﹤0.01% 1525
2016
Q1
$1.07M Buy
13,717
+10,643
+346% +$766K 0.01% 1111
2015
Q4
$224K Sell
3,074
-28,358
-90% -$2.02M ﹤0.01% 1894
2015
Q3
$2.33M Sell
31,432
-22,026
-41% -$1.58M 0.01% 821
2015
Q2
$3.43M Buy
+53,458
New +$3.7M 0.02% 673
2015
Q1
Sell
-3,452
Closed -$256K 2232
2014
Q4
$256K Sell
3,452
-14,146
-80% -$992K ﹤0.01% 1635
2014
Q3
$1.04M Buy
17,598
+7,298
+71% +$461K 0.01% 997
2014
Q2
$688K Buy
10,300
+6,478
+169% +$412K 0.01% 1073
2014
Q1
$232K Sell
3,822
-142
-4% -$8.46K ﹤0.01% 1655
2013
Q4
$211K Buy
+3,964
New +$209K ﹤0.01% 1573

Other funds holding IDXX

Jefferies Group's IDXX Position: Q3 2022 in Review

Jefferies Group opened a new position in Idexx Laboratories (IDXX) in Q3 2022: 6,500 shares worth $2.12M. The stake represents 0.02% of the portfolio and ranks #580 among its holdings. This is a return to the name: Jefferies Group previously reported a position in IDXX as recently as Q4 2021.

Jefferies Group first reported a position in IDXX in Q4 2013 and has held it in 26 quarters since. The position peaked at $7.28M in Q2 2017. 924 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

  • Jefferies Group held 6,500 shares of Idexx Laboratories worth $2.12M as of Q3 2022.
  • Idexx Laboratories was a new Jefferies Group position in Q3 2022.
  • Idexx Laboratories made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #580 holding.
  • Jefferies Group first reported a position in Idexx Laboratories in Q4 2013 and has held it in 26 quarters since.
  • Jefferies Group's Idexx Laboratories position peaked at $7.28M in Q2 2017.
  • 924 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.